Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
67,107.02 +218.23 (+0.33%) CMC Crypto 200
1,372.27 -1.58 (-0.11%)
Teva Pharmaceutical Industries Limited (TEVA.TA)
Tel Aviv - Tel Aviv Delayed price. Currency in ILA (0.01 ILS)
Add to watchlist
At close: 05:24PM IDT
Currency in ILA
Valuation measures4
| Market cap (intra-day) | 69.42B |
| Enterprise value | 131.66B |
| Trailing P/E | 921.38 |
| Forward P/E | 6.96 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.16 |
| Price/book (mrq) | 2.58 |
| Enterprise value/revenue | 2.24 |
| Enterprise value/EBITDA | 27.14 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.05 |
| 52-week change 3 | 109.25% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 6,297.00 |
| 52-week low 3 | 2,637.00 |
| 50-day moving average 3 | 5,123.94 |
| 200-day moving average 3 | 4,192.59 |
Share statistics
| Avg vol (3-month) 3 | 1.57M |
| Avg vol (10-day) 3 | 2.66M |
| Shares outstanding 5 | 1.13B |
| Implied shares outstanding 6 | 1.15B |
| Float 8 | 1.13B |
| % held by insiders 1 | 0.56% |
| % held by institutions 1 | 8.96% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 2.96 |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 28 Nov 2017 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 27 Jun 2004 |
Financial highlights
Currency in USD.Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -2.99% |
| Operating margin (ttm) | 17.28% |
Management effectiveness
| Return on assets (ttm) | 4.84% |
| Return on equity (ttm) | -9.67% |
Income statement
| Revenue (ttm) | 16B |
| Revenue per share (ttm) | 14.28 |
| Quarterly revenue growth (yoy) | 4.30% |
| Gross profit (ttm) | N/A |
| EBITDA | 4.46B |
| Net income avi to common (ttm) | -478M |
| Diluted EPS (ttm) | -1.55 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.99B |
| Total cash per share (mrq) | 2.64 |
| Total debt (mrq) | 19.94B |
| Total debt/equity (mrq) | 264.33% |
| Current ratio (mrq) | 0.89 |
| Book value per share (mrq) | 6.43 |
Cash flow statement
| Operating cash flow (ttm) | 1.39B |
| Levered free cash flow (ttm) | 3.57B |
© 2024 Yahoo. All rights reserved.